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1. Introduction 
1.1. Bacterial vaginosis 
1. 1. 1. Bacterial vaginosis (BV), the most common type of vaginal infection in women of 
reproductive age, accounts for at least one third of all vulvovaginal infections. Earlier names 
for the disease include non-specific vaginitis (1), Haemophilus vaginitis (2), Gardnerella 
vaginitis (3), Corynebacterium vaginitis (4), non-specific vaginosis (5), and anaerobic 
vaginosis (6). The vaginal secretions of women with the disease are characterized by 
exponentially greater numbers of anaerobic and aerobic bacteria than are the secretions of 
women without the disease. BV has been related to several clinically important infectious 
diseases of obstetric and gynaecologic patients. 
1. 1.2. History of bacterial vaginosis 
The microorganisms of the vagina have been studied since the late 1800s. 
Lactobacillus was first described as the predominant component of the normal vaginal flora 
in 1892 by Doederlein (7), whose name is an eponym, Doederlein's bacillus, for the 
organism. However, credit for characterizing and classifying the organisms belongs to 
Beijerinck, who gave it its current name in 1901 (8). Doederlein described three grades of 
vaginal cleanliness: grade I, a clean vagina, grade II, intermediate, and grade III pathological 
flora. Doederlein's bacilli, now observed as vaginal lactobacilli of various species, were 
recognized as the predominant organisms in the healthy (clean) vagina. Yeast and T. vaginalis 
were accepted as associated with vaginal signs and symptoms. A mixture of other organisms 
including curved, motile rods was also recognized as abnormal (pathological) flora. The 
syndrome associated with these organisms came to be known as „non-specific vaginitis" 
(NSV), to distinguish it from the specific vaginitis that were due to yeast and Trichomonas 
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(1). Gardner and Dukes characterized the syndroma of NSV clinically. The name of the 
syndrome was subsequently changed to BV to reflect the association with bacteria, as 
opposed to parasites or fungi, and to focus on the increased discharge without an 
inflammatory component. The syndrome has also been reported to as anaerobic vaginosis (6). 
1. 1.3. Microbiology of bacterial vaginosis 
A dynamic state of population equilibrium between aerobic and anaerobic bacteria 
forms the normal vaginal flora. In this equilibrium, Lactobacillus species account for 95% of 
the total number of organisms. The additional 5% consist of anaerobic organisms such as 
Bacteroides species, Prevotella bivia, and peptostreptococci, as well as facultative 
anaerobic/aerobic organisms such as Gardnerella vaginalis, Staphylococcus epidermidis, and 
Streptococcus species (9). The dominance of vaginal lactobacilli results from several factors. 
At the time of puberty, elevated serum and tissue estrogen levels increase the glycogen 
content of vaginal epithelial cells. The natural ability of vaginal lactobacilli to thrive on 
glycogen not only promotes their own growth but also curtails the growth of potential 
pathogens. The metabolism of glycogen by some species of lactobacilli produces lactic acid. 
This results in a normal vaginal pH of 3,8 to 4,2, which is suboptimal for the growth of 
Gardnerella vaginalis and anaerobes. Furthermore, certain species of lactobacilli produce 
microbial toxins such as H2O2, which may inhibit the growth of various microorganisms, 
including Gardnerella vaginalis, anaerobes, Neisseria gonorrhea, Chlamydia trachomatis, 
and Trichomonas vaginalis (9). A reduced concentration of normally abundant Lactobacillus 
species and a concomitant increased concentration of Gram-negative bacteria, such as 
Gardnerella vaginalis, Mobiluncus and Bacteroides species, Prevotella and Mycoplasma 
species characterize the pathologic flora in BV. A cascade of events begins with a reduction 
in the number of Lactobacillus species, resulting in the rise of vaginal pH. This increase in pH 
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favors the growth of Gardnerella vaginalis, which decreases the oxygen concentration. This 
relatively anaerobic environment favors the growth of anaerobic bacteria. So 
microbiologically, BV is charecterized by a shift in a normal vaginal flora of Lactobacillus 
spp. to a mixed anaerobic flora. The bacterial load also increases from 10 to 10 c.f.u./ml of 
vaginal fluid (10). Possible causes in the change of the flora include administration of 
antibiotics, use of vaginal medications, systemic hormones, contraception preparations, 
douches, sexual intercourse, and sexually transmitted diseases (STDs). The pathogenetic 
mechanism for BV is unknown, but it may vary from the use of topically applied substances 
with antimicrobial effect to alocalized immunologic defect or it may result from infection 
with an organism that competes or interferes with the lactobacilli. 
1. 1.4. Epidemiology of bacterial vaginosis 
As the most common cause of vaginitis, BV affects approximately 10-25% of patients 
in general gynaecologic and obstetrics clinics and in up to 64% of patients visiting STD 
clinics (11). Similar to trichomoniasis, 50% of women with BV are asymptomatic (11). 
Reproducible scientific evidence supporting the sexual transmission of B V is scant despite the 
higher disease prevalence among patients in STD clinics relative to that of the general 
population. Improvements in cure rate or reduction in recurrence rates after treatment of the 
partner can often be observed in sexually transmitted diseases. However, multiple studies 
have failed to demonstrate this effect in patients with BV. In addition, identical prevalence 
rates of BV have been found in sexually active adolescents and virginal adolescents (12). 
Some studies have shown a higher relative risk of acquiring BV in women with more sexual 
partners. BV is very common among lesbian women. Oral sex appears to be a risk factor for 
heterosexual and lesbian acquisition (13). Obstetrical sequelae of BV include: preterm birth, 
low birth weight, chorioamnionitis, and amnionic fluid infection (14, 15,16). Non-obsterical 
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infections incude postpartum endometritis, pelvic inflammatory disease, cuff cellulitis, 
neonatal scalp abscess, non-puerperal breast abscess and cervicitis (17). BV increases the 
acquiring of HIV infection (18). 
1. 1.5. Clinical manifestations, differential diagnosis 
Malodorous, fishy vaginal discharge is the most common symptom. The odor often 
exacerbated during menses and following intercourse. The alkaline nature of blood and semen 
favors the release of volatile amine byproducts of the anaerobic bacteria. The vaginal 
discharge is typically thin, dark or dull gray, homogenous and often frothy. Vulvar pruritus 
and irritation, common to yeast vaginitis, are rare. From the aspect of differential diagnosis, 
we should mention acute vaginitis and chronic vaginitis. In acute vaginitis the most common 
symptom associated with the infection of the vagina is discharge. Increased vaginal discharge 
is associated with an identifiable microbiological cause in 80 to 90% of cases. Hormonal or 
chemical causes account for most of the remaining cases. Three infective agents are 
responsible for most vaginal infections. BV accounts for 50% of infections; fungi 
(candidiasis) and protozoa (T. vaginalis) each account for about 25% (19). 
In addition, considering the three most common causes above, one (chronic vaginitis) must 
also evaluate alternative explanations for persistent symptoms. Chlamydia infection may 
present as vulvovaginitis. Overgrowth of Lactobacilli is a common cause of cyclic 
vulvovaginitis. Although the pathophysiology of this disorder has not been fully clarified, it is 
postulated that the overgrowth of the lactobacilli in the vagina may result in increased vaginal 
acidity, with subsequent cytolysis, vaginal discharge, and vulvovaginal irritation. 
Desquamative inflammatory vaginitis is characterized by purulent discharge, exfoliation of 
epithelial cells, and vulvovaginal burning and erythema. This condition is generally due to a 
relative absence of lactobacilli and overgrowth of Gram-positive cocci (19). 
1. 1.6. Diagnosis 
1. 1.6. 1. Clinical diagnosis 
The criteria developed by Amsel et al. in 1983 (20) are the current standard method 
for diagnosing BV. Clinically the diagnosis is made by identifying three of the following four 
findings: 
1: thin, dark (dull) gray, homogenous, malodorous discharge that adheres to the vaginal wall, 
2: elevated vaginal pH of greater than 4,5 
3: positive whiff/amine test and 
4: presence of vaginal epithelial cells (clue cells) - that are coated with small bacteria that 
obliterate the cell borders - on wet-mount microscopic evaluation. 
Gardnerella vaginalis was subsequently identified as the predominant organism on 
clue cells. Epithelial cells coated with Mobiluncus spp. have also been observed. These 
criteria have a sensitivity 90% and a positive predictive value of 90% (21). Gardner and 
Dukes (2) who recognized the presence of clue cells on saline wet mount, first described the 
clinical diagnosis of BV. They also described the discharge and elevated pH. A disagreeable 
but not offensive odor was also noted. Pheifer et al.(22) first noted the „fishy odor" on 
addition of potassium hydroxide to specimens that were being examined by KOH wet mount 
for yeast. The specimen collected for diagnosis should be taken from the posterior fornix 
taken care to avoid the cervix which has an usual pH> 4.5. The „fishy odor" is due to the 
presence of amines in the vaginal fluid, which become volatile when the pH is increased. 
Trimethylamine (23) is the likely source of the odor. Putrescine and cadaverine are also 
present. Both: M. curtisii and M. mulieris have been shown to reduce trimethylamine oxide to 
trimethylamine. A microbiological source for putrescin and cadaverine among the BV-
associated flora has not been found. Human cells do not manufacture these compounds. 
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1.1.6.2. Gram staining of vaginal fluid 
Gram stain has also been established as a reliable means for diagnosis and has the 
advantage of providing a permanent record. Standardized criteria developed by Spiegel et al. 
(24) yield a sensivity and specificity ranging from 62-100% and 79-100%, respectively. 
Nugent et al. (25) achieved excellent interobserver and intraobserver reproducibility of the 
Gram stain results by further modifying Spiegel's criteria into a scoring system. Nugent's 
scoring system categorizes vaginal flora as normal (Figure 1.), intermediate, or BV (Figure 
2.). Women with intermedier flora have an increased risk of gonorrhoea, chlamydia, and 
trichomoniasis and an increased likelihood of acquiring BV when compared with women with 
normal flora. 
Figure 1. Normal vaginal flora 
Gram stain of vaginal contents (lOOOx) shows an epithelial cell with well-visualized borders 
and Gram positive rods similar to lactobacilli. 
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Figure 2. Bacterial vaginosis 
Gram stain of vaginal discharge (lOOOx) from patient with bacterial vaginosis shows the 
borders of an epithelial cell obscured by small, Gram variable coccobacilli. 
1. 1. 6. 3. Papanicolaou Smear 
This technique was reported to have a sensitivity and specificity of 90 and 97%, 
respectively, in detecting BV when compared with clinical criteria (26). Unfortunately, these 
results could not be corroborated by subsequent studies. Davies et al.(27) showed that this test 
had a sensitivity of 55% and a specificity of 98%, making it an inadequat screening test for 
BV. Nonetheless, the same study also showed that Papanicolaou smears had a 96% positive 
predictive value. Hence, a positive Papanicolaou smear for BV obviates the need for 
additional confirmatory tests, but treatment can be instituted on the basis of this test alone. 
1. 1. 6. 4. Culture methods 
The sensitivity of a positive culture for anaerobic bacterial flora (Figure 3.) and 
Gardnerella vaginalis in patients with clinical signs of BV may be as high as 94%. However, 
the specificity of culture is only 50-60%, thus making it a less desirable diagnostic test. The 
low specificity is due to the large proportion of women with normal vaginal flora harboring 
Gardnerella vaginalis. The incidental finding of Gardnerella vaginalis from routine vaginal 
culture should never be used to diagnose BV (26). 
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Figure 3. Bacterial culture of typical BV vaginal flora after 5 days of anaerobic incubation in 
anaerobic blood agar 
1.2. Intraurterine devices (IUDs) 
1.2. 1. History of contraceptive intrauterine devices 
Although, the history of using intrauterine devices for contraception lasts for several 
centuries, the pioneer of intrauterine devices (IUDs) in the modern-day considered to be Dr. 
Ernst Grafenberg of Germany. In the late 1920s, he developed flexible devices made of 
silkworm gut or coiled silver wire (28). Over the past 4 decades IUDs have played an 
important role in reproductive health. In the mid-1970s when IUD use peaked, nearly 10% of 
all women using contraceptives (approximately 2, 5 million) were using the method (29). The 
first four devices ever mass-marketed were made of inert plastic impregnated with barium 
sulfate to make them radio-opaque; the Margulies Spiral (also known as Perma-Spiral and 
later sold as Gynekoil) was first used in the late 1960s and was still available in the early 
1970s. The Lippes Loop (1964-1986), Saf-T-Coil (1965-1984) and the Dalkon Shield came 
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later (30). We have to mention Professor Szontagh and the Szontagh-loop, developed by 
himself in the mid 1970s in Szeged. In the 1960s, researchers discovered that the 
effectiveness of small plastic devices could be improved by wrapping them in copper wire 
(30). In 1974, the first such IUD (CU-7, pronounced copper-seven) reached the US market, 
it's plastic frame was shaped like the number 7. Progestasert was the first hormone releasing 
IUD, and was sold for a quarter-century (1976-2001). The first T-shaped copper-bearing IUD 
was the TCu200, also known as Tantum-T, it's plastic frame was wrapped with copper wire 
that provided 200 mm2 of copper surface. In 1988, a device providing 380mm2 of copper 
surface (TCu380A) was marketed as ParaGard, and it is still available. The last IUD entered 
the market was Mirena (2001), this plastic device has a levonorgestrel-containing reservoir 
and releases 20ug per day of this synthetic hormone for 5 years. 
1. 2. 2. Contraceptive intrauterine devices- microbiological aspects 
Intrauterine devices (IUDs) are highly effective, long-term methods of contraception, 
however IUD use is limited to some regions due to concerns about increased risk of pelvic 
inflammatory disease (PID) and subsequent complications such as infertility and ectopic 
pregnancy. Some researchers have speculated that the presence of an IUD in the uterus may 
increase host susceptibility to infection, thus increasing the incidence of PID infections (31). 
In addition, some studies have shown that Actinomyces may proliferate significantly in the 
endocervix of women wearing an IUD (32,33). It has been shown that insertion of an IUD 
may contaminate the endometrial cavity with bacteria (34). Indeed, IUDs are considered to 
cause PID by leading vaginal and cervical bacteria into the uterus along the tail of the device. 
However, cultures obtained from the vagina of IUD users may or may not represent microbes 
present in the uterus (35). In fact, most of the microbes recovered from such cultures 
originated from the vagina. Therefore, bacteriological investigation of IUDs removed through 
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the cervix may represent contamination from the cervico-vaginal flora along with the 
microbial biofilm on the IUD. 
The major complication associated with the use of medical implants such as IUDs, 
intravascular catheters or tubes is infection. Microorganisms originating from the normal flora 
can colonize these devices and form biofilms, consisting of layers of host cells and 
bacteria/fungi, embedded within a matrix material. It turned out, that these foreign materials 
are the most probable sites of biofilm formation (36). The main component of biofilm 
produced by the bacteria and/or fungi is an exopolysaccharide layer. This exopolysaccharide 
is the pivotal factor responsible for the behavior of biomaterial-centered infection. The 
biofilm bacteria are usually resistant to attack by antimicrobial agents and host phagocytes. 
This is one reason to explain why infections caused by these microorganisms are hard to treat 
without removal of the devices. 
1. 2. 3. History of biofilm binding 
In 1982, in clogged oil pipelines mucus-like materiel was identified as the cause of 
clogging, which blocked the pipelines total lumen (37, 38). Tests performed on this occasion 
proved that this material had been formed by Pseudomonas aeruginosa, which was called 
biofilm. Later several spots were discovered in nature, where the presence of biofilm was 
identified: on the surfaces of rocks in the sea, on the leaves of plants. Subsequently a number 
of tests were performed in the fields of biological scientists to search for the presence of 
biofilms. The most often encountered bacteria have so far proved to be Enterobacter spp., 
Eserichia coli, Staphylococcus epidermidis, Staphylococcus aureus, Pseudomonas aeruginosa 
and Candida spp. were published in medical biological articles from 1987 (37, 39, 40). They 
founded a thick layer of biofilm formation on the surface of biliary calculi removed from 
patients suffering from chronic cholangitis which covered the bacteria Pseudomonas 
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aeruginosa, which had been responsible for the continuus infection (41). It turned out that the 
so-called foreign materials found in the organisms, injured tissues, biomaterials are the most 
probable sites of biofilm forming (39). Biofilm systems produced by microbial adhaesion and 
aggregation, mediated by mucoid alginate (glycocalyx) "slime" is of great interest because of 
their significance in almost all biologic systems. The exopolysaccharide glycocalyx produced 
by bacteria is the pivotal factor responsible for the behaviour of biomaterial-centred 
infections. The complex exopolysaccharide acts as an ion-exchange resign for enhanced 
nutrition, moderates susceptibility to phagocytosis and response to antibodies, and functions 
in later stages of surface adhaesion, aggregation, and polymicrobial interaction. The biofilm 
glycocalyx produced by Pseudomonas aeruginosa, Klebsiella spp., Staphylococcus 
epidermidis, and Candida albicans after colonisation of the respiratory, urogenital and biliary 
tract is a potent factor leading to intractable infection (42, 43). The biofilm bacteria are 
usually resistant to attack by microbial agents and host phagocytes. To treat such an infection 
it is important that extracellular polysaccharide or glycocalyx production- which occur at an 
early stage of biofilm formation - should be inhibited. In the past years, however, long-term 
administration of erythromycin, clarythromycin and azitromycin in combination of anti-
pseudomonas drugs as basic therapy had been used, and the prognosis of patients including 
those colonized by Pseudomonas aeruginosa has improved remarkably. Against this 
background, the influence of macrolides on mucoid alginate production by Pseudomonas 
aeruginosa was examined in vitro (44,45). The major complication associated with the use of 
medical implants such as intravascular catheters, tubes and intra uterine devices is infection. 
Microorganisms can colonise these devices and form biofilms consisting of layers of cells 
embedded within a matrix material. Although fungal infections are less common than 
bacterial ones, they tend to be more serious. The pathomechanism of biofilm forming can be 
illustrated by enumerating the phases of forming step by step, which are the following: the 
presence of inaminate, or relatively cell-free constituent, biofilm forming bacterium and 
biomaterial. Inoculation of a small quantity of biofilm forming bacterium, the opportunistic 
bacterium becoming pathogen. The resistance of the bacterium caused by biofilm is the 
cellular immunity of the host organism to antibiotic therapy. At the border of an injured 
tissue or foreign material, an intact tissue infection developes, which is caused by the 
necrotised tissue or the debris of the foreign material change in the cellular and possibly in the 
humoral immune response of the host organism caused by the foreign material (surface, 
debris) and the bacteria (capsule, toxin). In appropriate circumstances the primary adhesive 
force between the negative load bacteria and the surface of the foreign material forms the van 
der Waal's force. Beside this, hybrobic interaction also enhances their relation. The 
exopolysaccharide molecules produced in great amount further enhances the adhesions and 
the formation of receptor-ligand relations. The main component of biofilm is the alginate. 
This molecule is non-linear structured copolymer, containing B1, 4D mannuron acid and C5 
epimer L-glycuron acid (46, 47). Several theories have emerged to explain the production of 
exopolysaccharides. According to some theories the polysaccharide molecules get into the 
extracellular space through exocytosis. However with this mechanism one cannot explain the 
production of antibodies against the polysaccharide component (48, 39). This phenomenon 
can be explained by a theory, when the polysaccharide molecules are taken into the 
extracellular space by a carrier mechanism, and occasionally not only the polysaccharide 
molecule peels off, but a part of the carrier protein as well. This protein would be responsible 
for the antigen nature of the polysaccharide molecule. The peeling of part of the biofilm may 
lead to embolisation, formation of secondary infections (49, 50). 
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2. Aims of the study 
In the last decade, which saw a political and socio-economic transition after the fall of 
the regime, various changes in lifestyle have made their impact on the sexual habits of the 
Hungarian population. 
The primary aims of the thesis were: 
1.: to detect the correct prevalence of BV among symptomatic fertile women visiting the 
Department of Gynaecology of the Medical University of Szeged. Until this time no 
published data is known in this theme in the southern part of our country, and in Hungary 
also. All these women were previously tested for Neisseria gonorrhoeae with negative results. 
2.: to detect BV related conditions among patients infected by BV. 
The secondary objectives were: 
1.: to examine the bacteria present on removed IUDs of different ages by using aerobic and 
anaerobic culture methods. 
2.: in case of one patient with typical symptoms of PED beside quantitative culturing the 
biofilm bacteria of the removed IUD, scanning electron microscopy was also used for its 
visualization. 
19 
3. Materials and Methods 
3. 1. Materials and methods for investigation of the prevalence of bacterial vaginosis 
From 01. September 2001. until 01. April 2003. 4 611 non-pregnant, sexually active 
women above 16 years of age who were presented for a pelvic examination, regardless of the 
reason, were eligible for entry into the study. Participants completed a self-administered 
questionnaire. The following information was collected: age of sexual debut, sexual 
orientation, number of lifetime sexual partners, number of partners in the last 6 months, date 
of last sexual contact, contraception utilised, use of condoms with last sexual partner, history 
of sexually transmitted infections (STI), last menstrual period, date of last Pap smear, and Pap 
smear results. The patient's major complain as well as clinical findings of abnormal vaginal 
and/or cervical discharge, vaginal pH, and an amine odour test were recorded. The protocol 
and consent forms were approved by the Department of Gynaecology, Medical Faculty, 
University of Szeged. 
3. 1. 1. Specimen collection 
The clinical diagnosis of BV was made at the outpatient clinic by the gynecologist, 
and it was based on both the Amsel's criteria and the Gram-stain results, which were 
immediately available. A vaginal speculum, lubricated with water only, was inserted, and 
vaginal fluid was collected from the posterior fornix with two cotton swabs. One swab was 
used for pH determination and preparation of a slide for Gram-staining. The swab was 
rotated, removed, and inserted into a protective container without any liquid medium. Vaginal 
swabs were rolled onto a clean glass slide, labelled with the study identification number, air 
dried, and were sent to the Institute of Clinical Microbiology and Gram stained. The microbial 
diagnosis of BV was made based on criteria described by Nugent et al. (25). The vaginal fluid 
with the second swab was sent, in aerobes/anaerobes and mycoplasma transport medium to 
the Institute of Clinical Microbiology for culture detection of micro-organisms. Amine odour 
was tested after removal of the speculum by adding 10% potassium hydroxide to the posterior 
lip of the speculum. 
3. 1.2. Interpretation of Gram-stained vaginal smears 
In the quantity of three morphotypes detected per oil immersion field were identified 
and scored. For Lactobacillus morphotypes (i.e., Gram-positive rods), the values ranged from 
0 to 4, with a score of 4 indicating that no organisms were found and a score of 0 indicating 
that 30 or more organisms were found in the sample. For Gardnerella and Bacteroides 
morphotypes (i.e., small Gram-negative rods or Gram-variable rods), values ranged from 0 to 
4; a score of 0 indicated that no organisms were found, and a score of 4 indicated that 30 or 
more organisms were detected. For Mobiluncus morphotypes (i.e., Gram-negative curved 
rods), the values ranged from 0 to 2, with a score of 2 indicating that, 5 organisms were 
identified in the sample. 
3.1.3. Culture methods 
The vaginal discharges were cultured on Columbia agar plates supplemented with cow 
blood aerobically for 48 hours in parallel with Sabouraud agar, and on blood agar plates 
supplemented with vitamin K1 and hemin in an anaerobic chamber for 6 days. The 
identification of the isolates was carried out by conventional methods and in some cases of 
aerobic and anaerobic bacterias by different stripps of the API-System. (BioMerieux Marcy 
TEtoile, France) On CHROM agar (BD) for isolation of the yeast's C. albicans, C. glabrata, 
C. tropicalis and C. krusei were identified on the basis of the typical colours of their colonies 
on ChromAgar Candida (BD). All other fungal species were identified with ATB 32C and/or 
API AUX 20 (BioMerieux Marcy FEtoile, France). In vitro antibiotic activities testing were 
of aerobic bacteria with agar diffusions method. The in-vitro susceptibilities of anaerobic 
bacteria and of various Candida isolates to antifungal agents were determined by the Etest 
method (AB Biodisk, Solna, Sweden). For isolation of Mycoplasma hominis (.M. hominis) 
and Ureaplasma urealyticum (U. urealyticum) Mycoplasma-Duo (Sanofi Diagnostics) was 
used. 
3. 2. Materials and methods for investigation of biofilm formation on IUDs 
3. 2. 1. Patients 
127 participants were recruited for our study among women who visited the Out-
patient's unit of the Department of Obstetrics and Gynecology, University of Szeged, between 
01. January 2001 - 31. December 2003. The mean age of the women was 41 years; ranging 
between 28 and 56. All participants underwent the following clinical and laboratory 
examination: history and physical examination (including pelvic examination) and 
transvaginal ultrasound. If signs and/or symptoms of genital tract infection were present 
patients were screened for vaginal and cervical infections, according to our microbiology 
laboratory's practice. The IUDs were removed under antiseptic conditions. After careful 
cleaning of the cervix and the vaginal wall with antiseptic solution (Braunol, B. Braun 
Medical AG, Emmenbriicke, Switzerland; in the case of iodic allergy Kodan Forte, 
Schulke&Mayr GmbH, Norderstadt, Germany), the removals were performed without 
touching the vaginal wall or the opener instrument with the IUDs to prevent contamination by 
the vaginal flora. 
A 41-year old patient with two previous live births was selected with typical 
symptoms of PID and with a 10-year old Copper-T IUD. After removal of the IUD, it was 
sent for scanning electron microscopic examination simultaneously with culturing in the 
microbiology laboratory. 
3. 2. 2. Microbiological methods for vaginal flora assessment 
From those women who had signs and/or symptoms of genital tract infection vaginal 
and cervical swabs were collected. The first vaginal swab was used for aerobic and anaerobic 
cultures; the second swab was used for detection of Mycoplasma hominis and Ureaplasma 
urealyticum. Vaginal swabs were directly inoculated onto: Columbia blood agar plates 
(Oxoid, Basingstoke, UK), which were incubated aerobically at 37 °C for 48 hours to isolate 
aerobic bacteria, including lactobacilli; Columbia human blood agar plates, which were 
incubated anaerobically at 37 °C for 5 days to isolate Gardnerella vaginalis and the bacterial 
vaginosis (BV) associated anaerobic bacteria; Thayer-Martin agar (Oxoid, Basingstoke, UK) 
was used to isolate N. gonorrhoeae, Sabouraud's agar plates (bioMerieux, S.A., Marcy 
l'Etoile, France), which were incubated at 37 °C for 48 hour to isolate Candida spp. 
"Mycoplasma DUO" (Sanofi Diagnostics Pasteur, Paris, France) was used for quantitative 
assessment of the presence of M. hominis and U. urealyticum after incubation for 48h. 
Isolated bacteria and fungi were identified by using classical methods and/or ATB/VITEK 
identification procedures (bioMerieux, S.A., Marcy l'Etoile, France). The presence of 
Chlamydia trachomatis on the cervical swab was looked for by the MicroTrak II Chlamydia 
antigen detection kit (Trinity, Biotech, Ireland). 
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3. 2. 3. Microbiological examination of the removed IUD 
All cultures were commenced within 1 hour of sampling. Each IUD sample was 
immediately sent to the microbiology laboratory where it was placed in 10 ml reduced BHI 
(Brain Heart Infusion pH 7.2) broth (Oxoid, Bakingstoke, UK) and mixed on a Vortex shaker 
for 30s. After gentle dispersion the suspensions were diluted ( lO'- lO6) in reduced BHI broth 
and 100 pi of each dilution and 100 pi of the corresponding undiluted suspension were plated 
immediately on selective and non-selective media. Columbia agar base (Oxoid, Basingstoke, 
UK) supplemented with 5% (v/v) cattle blood, haemin and vitamin Kj was used to enumerate 
the total cultivatable bacterial flora, chocolate agar was used for calculation of the total 
aerobic bacterial flora. For the selective growing of Enterobacteriaceae, Endo agar 
(bioMerieux, S.A., Marcy l'Etoile, France) was applied. Fungi were selectively cultured on 
Sabouroud Dextrose agar (bioMerieux, S.A., Marcy l'Etoile, France). Black-pigmented 
anaerobic bacteria (Prevotella sp., Porphyromonas sp.) were isolated from KVLB 
(Kanamycin Vancomycin Laked Blood Agar) (Oxoid, Basingstoke, UK). CFAT (Cadmium-
Fluoride- Acriflavine-Tellurit agar) (Oxoid, Basingstoke, UK) agar was used for isolation of 
anaerobic Actinomyces spp. For the isolation of anaerobic organisms and determination of the 
total cultivatable aerobic and anaerobic bacterial count, cultures were performed in an 
anaerobic chamber with an atmosphere of 90% N2, 5% H2, and 5% CO2 (Bactron Sheldon 
Man, Oregon, USA) for 5 days at 37 °C. Isolated bacteria and fungi were identified by using 
classical methods and/or ATB/Vll'EK identification procedures (bioMerieux, S.A., Marcy 
l'Etoile, France). 
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3. 2. 4. Scanning electron microscopy 
The 10-year old IUD, removed because of the symptoms of PID, was cut into 1cm 
stripes with sterile scissor, which was followed by the process of chemical dehydration (in 30-
50-70-90 100% alcohol for 1-1 hour each, then in 30:70, 50:50, 70:30 alcohol:aceton mixture 
for 20-20 minutes). The samples were placed in the critical point drier in 100% aceton, and 
rinsed three times in liquid CO2, then the critical point was identified, after which the samples 
were secured onto racks and coated in gold in a sputter coater. The examination was carried 
out with a Hitachi S 2400 scanning electron microscope (Tokyo, Japan) and the pictures were 
digitally recorded. 
4. Results 
4. 1. Results for bacterial vaginosis and other vaginal pathogens (Paper I.) 
Out of 4 611 examined patients with symptoms of vaginal discharge 1 567 (34%) 
proved to be positive for bacteria, fungi or T. vaginalis by culture methods. Almost 
twenty-four percent of the positive samples harboured a typical Bv flora (mixed 
anaerobic bacteria) (Table 1.). 
Table 1. Distribution of different pathogens in 1 567 culture positive 
vaginal specimens 
Species No/ (%) 
Mixed anaerobes (BV) 374/ (23.76) 
Mycoplasma hominis 253/(15.15) 
Ureaplasma urealyticum 367/ (23.42) 
Candida spp. 281/(17.93) 
Trichomonas vaginalis 447/ (28.52) 
Others aerobs 312/(19.91) 
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The presence of M. hominis and U. urealyticum was confirmed in 15.15% and 23.42% 
respectively. In 18% of the cases vaginal candidiasis was found. T. vaginalis was 
isolated in 28.52% of all culture positive samples. Nearly 20% of the cases different 
aerobic bacteria were found. The simultaneous presence of BV flora, M. hominis, U. 
urealyticum, Candida spp. and T. vaginalis and some bacteria was also found (Table 
2.). 
Table 2. Coexistance of other vaginal pathogens with BVs 
BACTERIAL VAGINOSIS No. 374 
with Trichomonas vaginalis 48 
with Enterococcus faecalis 36 
with Candida spp. 32 
with Streptococcus agalactiae 29 
with Ureaplasma urealyticum 24 
with Mycoplasma hominis 13 
The low level of coexistence of M. hominis with B V in these patients may be due to 
their earlier empirical treatment with macrolids or tetracyclin. The distribution of 
anaerobic bacteria in clinically confirmed BV patients (374) can be seen in Table 3. 
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Table 3. Anaerobic bacteria isolated from bacterial vaginosis 
Gram positive anaerobes No of isolates 
Peptostreptococcus spp. 225 
Propionibacterium spp. 157 
Bifidobacterium spp. 52 
Eubacterium spp. 21 
Gram negative anaerobes 
Bacteroides fragilis 158 
Bacteroides spp. 46 
Fusobacterium spp. 73 
Prevotella spp. 198 
Porhyromonas spp. 78 
Mobiluncus spp. 264 
Total anaerobes 1 272 
On average 2.76 anaerobic bacteria could be isolated from one patient. The distribution 
of the Candida species isolated from this population is shown in Table 4. 
Table 4. Distribution of the yeast isolated in 281 cases 
Species No/ (%) 
Candida albicans 219/(77.93) 
Candida krusei 33/(11.74) 
Candida glabrata 19/ (6.76) 
Candida tropicalis 8/ (2.84) 
Candida spp. 2/ (0.71) 
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The most prevalent Candida isolate in these patients was Candida albicans (77.9%). 
However quite numerous cases were found where behind the symptoms Candida 
glabrata (6.8%), Candida tropicalis (2.8%) or other Candida species were isolated. 
Fluconasole resistant C. krusei strains were found in 33 cases. 
The Gram-stained direct smears of the 4 611 samples were also evaluated (Table 5.) 
Table 5. Bacterial morphotypes found by Gram stain in the case of 
4 611 cases 
Morphotypes No 
Lactobacilli 2020 
No lactobacilli, no other bacteria 425 
BV (typical clue cells) 347 
Curved Gram-variable rods 251 
Fusiform bacteria 275 
Gram-variable rods 301 
Gram-negative rods 172 
Gram-positive cocci 301 
Yeast 267 
In 95% of cases where the culture was positive for Candida spp. the yeast were already 
seen in the direct smear. However fewer cases proved to be BV according to the results 
of the culture than was judged based on the investigation of the direct smear. The mixed 
aerobic-anaerobic flora cannot be always evaluated according to the direct smear 
morphotypes. Culture for aerobic and anaerobic bacteria of these specimens obtained 
from therapy resistant recurrent cases of BV or BV-like cases is advisable. 
28 
4. 2. Results of the studies on intrauterine contraceptive devices (Paper II.) 
Out of the 127 patients involved in this study 10 were selected as control group with 
an IUD which was removed before 1 year of wearing. Due to the poor patient compliance 
some extremely old IUDs were also found. Among the investigated 117 patients (study 
group), in 63 cases (53.8 %) the supplementary reason of the removal was the age of the 
device. The manufacturer's recommendation for duration of an IUD in situ is 4 to 5 "years, 
depending on the type of the device. In our material only 22 devices (18.8 %) were younger 
than 5 years (1-5 years, mean time in situ 2.5) (group 1). In 44 cases (37.6 %) the patients 
wore their device for 5 to 10 years (group 2), and in 51 cases (43.5 %) we found devices 
which were in situ for more than 10 years (group 3) (Table 6.). In two cases we removed 20 
years old IUDs. 
Table 6. Summarized culture results of 127 IUDs with different years in situ 
Age of the IUD 
(No.) 
No. of patients 








Average no. of 
species 
Control (10) 0/10 12/10 0 - 2 1.2 
< 5 years (22) 6/11 26/22 0 - 2 1.2 
5 - 10 years (44) 8/15 144/44 1 - 4 2.6 
>10 years (51) 11/15 298/51 5 - 8 5.8 
In 78 cases (66.6 %) the cause of removal of the IUD was the different degree of 
inflammation, including PID. In 14 cases (11.9 %) IUDs were removed because of 
metrorrhagia. One 41-year old patient with two previous live births visited our Out-patient's 
unit with expressed lower abdominal pain. By bimanual examination bilateral adnexal 
tenderness, cervical motion tenderness and lower abdominal tenderness was found. She had 
no fever at the time of the visit, however the transvaginal ultrasound showed free pelvic fluid. 
After PID was diagnosed the 10-year old Copper-T IUD was removed. 
In the control group 9 of 10 (90%) IUDs had a <103 CFU bacteria/sample, however in 
the study group 7 of 117 (5.9%) IUDs had the same low level presence of bacteria/sample. In 
patient group 1, 11 patients had vaginal culture results. In 6 cases the typical BV flora was 
found dominated by black pigmented anaerobic bacteria including Mobilluncus spp. No 
lactobacilli were present. From the 22 IUD samples 26 species were identified, the average 
number of species/IUD was 0.8 (Table 1). In patient group 2, 15 had symptoms or sings of 
vaginal discharge. Out of these 8 had typical culture result of BV. Altogether 144 species 
were isolated with an average number of species/IUD 2.6. In patient group 3 out of the 15 
patients who had symptoms of vaginal discharge 11 had BV flora in the vaginal fluid. 298 
species were isolated from the 51 removed IUDs with an average number of species/IUD 5.8. 
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Table 7. Shows the prevalence of the aerobic and anaerobic bacterial species and Candida 
albicans isolated from the 51 IUDs worn more than 10 years. 
Table 7. Detailed culture results of 51 IUDs removed after >10 years 
Species Number of IUDs positive 










































Table 8. Total CFUs of bacteria and yeasts isolated from the IUDs different ages in situ. 
Total bacterial count 
(CFU/sample) <1 
(control) 
Number of IUDs used for years 
<5 5-10 >10 
<103 9 6 0 1 
104 1 9 13 9 
105 0 0 9 9 
106 0 5 7 11 
>107 0 2 15 21 
Table 8. summarises the distribution of the IUDs with different ages in situ, according to the 
total bacterial CFUs found during cultivation. In the case of those belonging to the control 
group the highest number of CFU/IUD was 104/sample. Low total bacterial counts were 
dominant among the IUDs <5 years old, however in the two other groups (IUDs removed 
after 5-10 years or >10 years in situ) we found significantly more IUDs with higher number 
of bacteria/IUD. It was remarkable that not only the CFU/IUD, but also the number and 
diversity of species isolated from the IUDs increased with the time in situ. 
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The distribution of aerobic and anaerobic bacteria on the IUDs with different ages is 
shown in Figure 4. 
Figure 4. Percentage of the IUDs with different ages with positive 
cultures for aerobic and anaerobic bacteria 
<5y*ars 5-10j«trs > 10 years 
•aeiobe negative and anaerobe negative (Daerobe psitive and anaerobe regative 
•aerobe negative and anaerobe psitive 0aerobe psitive ard anaerobe psitive 
It is remarkable that from the biofilm on IUDs over 10 years anaerobic bacteria alone or in 
combination with aerobes could be isolated more frequently. 
In the case of the 41-year-old patient (Paper HI.), whose IUD was removed after 10 
years because of symptoms of PID, a very complex anaerobic bacterial flora was isolated. The 
total CFU/sample was 2.5x108. Beside Gram-positive anaerobes (Actinomyces viscosus, 
Actinomyces naeslundii, Bifidobacterium sp, Finegoldia magna, Anaerococcus prevotii) 
Gram-negative anaerobes were dominant (Prevotella disiens, Porphyromonas 
asaccharolyticus, Bacteroides ureolyticus). One of the key pathogens in BV (Mobiluncus sp) 
was also present. 
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No cultures were carried out from the vaginal fluid of this patient, so it was not possible to 
compare the comparison of the biofilm flora with the vaginal flora. Figure 2-4. showing an 
immature, and a mature part of the biofilm and the surface of the IUD also. 
Figure 5. Scanning electron microscopic picture from the immature part of the biofilm 
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Figure 6. Scanning electron microscopic picture of mature bacterial biofilm 
Figure 7. Around the forming biofilm the surface of the IUD can be seen 
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5. Discussion 
5. 1. Bacterial vaginosis (Paper I.) 
BV is the most frequently found pathological condition of the female genital tract. Changes in 
mental attitudes relating to sexual life, promiscuity, prostitution, the effects of drugs and 
alcohol, and the beginning of sexual activity at younger age, all involve the possibility of 
acquiration an infection. The disturbance in the vaginal flora frequently coexists with the 
inflammation of the uterine cervix. Cervical inflammation, characterized by mucopurulent 
discharge from the cervical os at the time of physical examination, is a condition frequently 
affecting young, sexually active women. Although some cases are linked to chlamydial 
infection or gonorrhoea, the causes of at least half are unknown. The apparent lack of a host 
inflammatory response to BV, as suggested by the absence of polymorphonuclear leukocytes 
in the vaginal fluid of women with BV, led to use of the term vaginosis, as opposed to 
vaginitis. However, BV may be associated with less visible inflammatory markers such as 
lactoferrins or various cytokines. BV has been associated with many STIs, HIV disease and 
cervicitis (51, 52, 53, 54, 55, 56, 57, 58). The leading hypothesis concerning these 
associations is that the absence of protective lactobacilli increases the biologic risk for 
acquiring an STI upon exposure. The mucopurulent discharge of the cervical os, oedema and 
easily induced endocervical bleeding can be observed. In a study by Paavonen et al. (59) 50% 
of women attending a clinic for treatment of STIs who had cervicitis, also had BV. The 
authors further hypothesized that cervical inflammation might predispose to altered vaginal 
flora. In a pilot study examining appropriate treatment for patients with BV and cervicitis, it 
was found that specific therapy for BV (metronidazole), along with standard antimicrobial 
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therapy for cervicitis, was necessary for cure of BV. It was further observed that resolution of 
BV was associated with the resolution of cervical inflammation (17). 
Calzolari et al. (60) investigated a possible association between BV and the use of 
different contraceptive methods as compared to non-users. They didn't observe a significant 
difference in the BV positive group between condom or diaphragm use as compared with 
women without BV. Women with BV used an IUD significantly more often than women 
without BV, while there was a significantly negative association between BV and OC use. 
Similarly a negative association between condome use and the occurrence of BV was 
observed. They also found a significant association between previous induced abortion and 
BV. Their results suggest that the use of OC and condoms protect against BV, but the 
protection is less appreciable for the use of condoms. These findings of protective effects of 
OC and condom use against BV are difficult to explain. Several studies suggest that the use of 
OC increases the glycogen content of vaginal epithelial cells. Glycogen is a substrate for 
production of lactic acid by lactobacilli, which inhibit the in vitro growth of certain bacteria 
including BV-associated organisms. Haukkamaa et al. (61) suggests that barrier contraception 
with a condom prevents the anaerobic shift of vaginal flora and maintains a lactobacilli 
dominated flora. Avonts et al. (62) pointed that the tail of IUD present in the endocervix or in 
the vagina may favor the growth of vaginal anaerobic bacteria and Gardnerella vaginalis, 
which presumably play a role in the pathogenesis of B V. 
It has been suggested that the group of organisms responsible for BV may cause PID. 
Paavonen et al. (59) used a histological diagnosis of endometritis in association with clinical 
criteria (and confirmed by laparoscopy) to define upper genital tract infection, and found an 
association between this and BV based on gas-liquid chomatographic findings. Kristiansen et 
al. (1987) also showed a correlation between the isolation of Gardnerella vaginalis the signal 
bacterium of BV and endometritis. Pelvic infection is the most common but preventable cause 
of infertility. The damage that occurs is usually irreversible and cannot be corrected by 
current techniques, except with the use of in vitro fertilization. 
The incidence of PID (especially acute PID) has increased in the last few years. The 
most dramatic increase is in the age group between 20 and 24 years. Of these women with 
PID more than 20% will become fertile because of the infection and more than 3% will 
experience an ectopic pregnancy (63). 
Schwebke et al. (17) found in their study, that among those women treated with 
metronidazole gel, those, whose BV resolved were significantly more likely to have cervicitis 
resolve than were those with persistent BV. The total cure rate was 70% for the BV, similar to 
those reported in the literature. What highlights the importance of BV is that in those cases 
where BV resolved by metronidazole, 100% had cervical inflammation resolve (17). The 
potential effects of metronidazole on cervical inflammation could be due to nonspecific 
antiinflammatory properties of the antibiotic or specific interactions with BV or an 
unrecognized pathogen. Although antiinflammatory properties of metronidazole have not 
been demonstrated in vitro (17), this antibiotic is widely used as adjunctive therapy along 
with oral antiinflammatory agents for Chron's disease. Alternatively, there may be a specific 
component of the largely anaerobic flora associated with BV that is pathogenic in cervical 
tissue and is eradicated by metronidazole. 
BV does not affect conception, but is associated with an increased risk of miscarriage 
in the first trimester. In women undergoing in vitro fertilisation, independent of other risk 
factors Ralph et al. (56) found a significantly increased risk of miscarriage (36.1% v. 18.5%) 
in women with bacterial vaginosis compared with women with normal vaginal flora. This was 
the first study to describe a definite association between BV and miscarriage in the first 
trimester, and it suggests that the pathological process of BV may begin early in pregnancy. 
These results are genuine because they eliminated other infective causes of miscarriage. The 
association between BV and miscarriage in the first trimester persisted after adjusting for 
other variables known to increase the risk of miscarriage-namely, smoking, older age, three or 
more previous miscarriages, polycystic ovary syndrome, and no previous live births. An 
increasing miscarriage rate was seen with increasing abnormality of the vaginal flora: 18.5% 
in women with normal vaginal flora, 23.3% in women with intermedier vaginal flora, and 
36.1% in women with BV, as would be expected with a cause and effect relation. The 
pathogenesis of miscarriages with BV is not known. If endometritis was present with BV 
before in vitro fertilisation, this could impair implantation or early embryonic development. 
A meta-analysis to evaluate BV as a risk factor for preterm delivery found that BV 
increased the risk of pre-term delivery >2 fold, significantly increased the risk of spontaneous 
abortion and maternal infection (64). 
For the treatment of asymptomatic BV to prevent pre-term delivery Guaschino et al. (65) 
made a randomized trial to evaluate the effect of 2% clindamycin vaginal cream. Among 
women who completed the study, the rates of preterm delivery were 12.2% in the clindamycin 
group, and 15.7% in the no treatment group. 
The idea of pH self measurement was developed by Saling at the beginning of the 
1990s. The main benefit is that because of the active involvement of the pregnant women pH 
changes could be recognised as early as possible and as a consequence a huge part of the 
disorders relevant for late miscarriage or premature birth could be addressed with an 
immediate adaequate therapy. 
In two prospective investigations, the effectiveness of the self care programme for 
prematurity prevention was investigated by Hoyme and Saling (66). Pregnant women have 
been offered to perform self measurements of their vaginal pH by means of test gloves twice a 
week in order to screen for any disturbances in the vaginal milieu. The women were 
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instructed to see their physician immediately, if abnormal pH > 4.7 or other risk factors were 
present, in order to get them confirmed and to start lactobacillus acidophilus therapy or in 
case of bacterial vaginosis to treat with clindamycin cream in the vagina. Patients who were 
not interested in the programme served as a control group. They found the prematurity rate 
8.1% in the self measurement group, and 12.3% at the control group. 
There are recent publications on new technologies for diagnosis of BV in resource-
poor health care settings is often overlooked; there is a need for cheap, easy, rapid objective 
point-of-care diagnostic test. West et al. (67) tested the FemExam card, where card 1 is for pH 
and amines, and card 2 measures proline iminopeptidase (PIP) activity. They found the 
FemExam card 1 had a sensitivity of 71.4% and specificity of 72.8%, FemExam card 2 had a 
sensitivity of 70% and the specificity of 81%, and FemExam card 1 and 2 combined had a 
sensitivity of 91% and specificity of 61.5%. Chaim et al. (68) tried a new analytical method 
based on ion mobility spectrometry (IMS). It is an instrumental technique for identifying 
compounds and determining their concentrations, based on measurement of the velocity of 
ions drifting through air at atmospheric pressure under the influence of an electric field. The 
technique is particularly sesitive to amines taking less than 2 minutes. During the 
investigation the diagnostic procedure showed high accuracy and was found technically 
simple and rapid. 
Little is known about bacterial vaginosis after the fertile period. We have only a few 
datas on the effect of hormone replacement therapy on the prevalence of BV. In a cohort 
study Cauci et al. (69) found that the prevalence of BV and abnormal flora in postmenopausal 
women are statistically lower than in premenopausal women. No significant differences in the 
prevalences of BV and abnormal anaerobic flora were seen in fertile and perimenopausal 
women. Among postmenopausal women, hormone replacement therapy (HRT) does not 
significantly affect the prevalence of either full BV or abnormal anaerobic flora. The absence 
of lactobacilli in the absence of BV increased markedly in postmenopausal women who are 
not taking HRT, compared with premenopausal women - this condition must be distinguished 
from the partial decrease in lactobacilli associated with a limited increase in BV-associated 
bacteria. It was found that in women taking HRT, the colonisation of Lactobacillus spp. 
completely restored to the same level as seen in fertile women. 
In our recent study, the 23.76% of culture positive cases showed typical BV flora. It is 
similar to the rates found in industrial countries outside the USA. Comparing these results 
with the results of Gram-stained smears shows that according to the other studies, culture of 
vaginal secretion is not as helpful as microscopic diagnosis of BV. In our results, sensitivity 
of culture method compared to Nugenf s method was 93% respectively. 
According to Amsel's criteria, the diagnosis of BV is simple and the treatment is 
cheap. By restoring the normal vaginal flora we get a much better background for the cure of 
a possible genital infection. 
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5. 2. Discussion on contraceptive intrauterine devices (Paper II.-III.) 
The use of IUDs is highly effective in preventing pregnancy and it is also very cost-
effective. It is one of the most popular method of contraception in the world today. More than 
80 million women are using IUDs for contraception world wide and the effectiveness rivals 
with that of tubal sterilization (31). Recent reviews suggest that the overall risk of PID with 
modern IUDs is lower than previously thought, at least in regions where medical advice is 
followed by the patients, and where low prevalence of sexually transmitted infections (STIs) 
exists. The risk of PID may be higher, however, in places where gonorrhoea and chlamydia 
are prevalent, where screening for STIs is limited and where aseptic conditions for insertion 
are difficult to ensure (70). It is hard to explain the reasons behind the extreme long wearing 
of the IUDs in a great part of our patients, but it seems to have connection with lower 
education and careless personal hygiene habits. 
Guerreiro et al. (71) found significantly higher prevalence of any infection in IUD 
users in comparison with users of other methods as a result of higher prevalence of B V in this 
population. These data are in agreement with those published by Ferraz do Lago et al. (35) 
who found the prevalence of cervicovaginal infections 29.1%, and BV was frequently found 
(19.7%) among IUD users after 6 months of insertion. In his study he found that 
dysmenorrhoe and the trend of abnormal bleeding was more recurrent in patients with BV. 
The incidence of BV among IUD users can be even higher (47.2%) as noted by Joesoef et al. 
(72). In our study quite a few patient in all three patient groups who had symptoms or signs of 
genital infection had BV flora, when tested their vaginal flora. In those cases BV specific 
anaerobic bacteria were also found more frequently and in higher numbers on the removed 
IUDs as well. 
There are numerous publications in the literature showing a higher risk of PID in the 
first weeks after IUD insertion (73, 74). The main agents responsible for PID in connection 
with the use of IUDs are Chlamydia trachomatis and Neisseria gonorrhoeae, which can be 
present in the endocervix at the time of insertion and transferred to the upper genital tract by 
the device. In our case no patient was found among those who were tested with Chlamydia 
trachomatis or Nesseria gonorrhoeae positive results. Farley et al. also suggest that one 
reason why IUDs that have been in place for a long time are associated with more PID is that 
aseptic practices during insertion have significantly improved over the years, and more 
recently inserted devices are less likely to be infected. 
Prophylactic antibiotics are not necessary to be administered routinely at the time of 
insertion only if the patient has positive culture (75). In a meta-analysis by Grimes et al. (76) 
the antibiotic prophylaxis for IUD insertion (either oral doxycyclin or azithromycin) 
significantly reduced the frequency of unscheduled return visits. The protection against PID 
was higher if antibiotic prophylaxis was used, but not statistically significant. In a technology 
assessment study, which analyzed the effectiveness of follow-up visits after IUD insertion 
Neuteboom et al. (77) compared a group of women with regular follow-up visits in the first 
year with women who had no regular follow-up visits. Patients in the regular follow-up visit 
group came more frequently for unscheduled visits. They concluded that regular follow-up 
after the insertion of an IUD is not effective. Patients of this study did not make big effort on 
following medical advice on regular follow-up visits or removal of the IUD after 4-5 years. 
The majority of the patients, 95 out of 117 (81%), had an IUD older than 5 years. Our data 
show a close correlation between the change in the number and type of the microbial flora and 
the proportion of patients with BV the longer the IUD was in place. This supports the 
recommendation for wearing the IUD for five years and not longer to ensure safety. The 
complexity of the biofilm flora and the dominance of the anaerobic bacteria on the IUDs older 
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than 5 years, were remarkable regardless whether the patient had a BV flora in their vagina or 
had no symptoms or signs of genital infection. 
There are few recent data in the literature about the investigation of bacterial biofim 
formation on IUDs with different ages by quantitative culture methods. Scanning and 
transmission electron microscopic study of the surfaces of IUDs have already been reported 
by Marrie et al. (78). His transmission electron microscopy study showed highly organized 
and often densely packed micro-colonies of bacteria, given the possibility that the majority of 
these bacteria have been present on these surfaces for a long time. In our case a 10-year old 
IUD was examined for biofilm formation parallel with the culturing. An expressed biofilm 
formation was detected on the surface of the IUD involving both coccal and bacillary forms 
by scanning electron microscopy. Quantitative culture of aerobic and anaerobic bacteria 
showed a dominance of anaerobic bacteria in this biofilm. Bacteria living in such a biofilm 
are usually resistant to attack by antimicrobial agents and host phagocytes. To treat PIDs 
which develop in connection with the IUD wearing requires the immediate removal of the 
IUD and an antibiotic treatment of the inflammation active against bacteria colonizing the 
IUDs. 
6. Conclusions 
1., In the detection of the prevalence of BV among symptomatic fertile women visiting our 
department, we examined 4 611 patients. By culture methods 1 567 (34%) proved to be 
positive for pathogenic bacteria, fungi in sugnificant number, or we detected T. vaginalis. 
374 (24%) of the positive samples harboured a typical B V flora. For the examined population 
the prevalence of BV was 8.11% (374). Our results seems to be the first published data for the 
prevalence of BV in Hungary. 
2., By detecting BV related conditions we have found low level (3.47%) of coexistance of M. 
hominis, which may be due to their earlier treatment. We could isolate great number of 
anaerobic bacteria (2.76 bacteria/patient) either Gram positives and negatives, also. Candida 
species isolated in 281 (75.1%) patients. The most prevalent Candida isolate in these patients 
was Candida albicans 219 (77.9%). 
3., In our material in 78 cases (66.6%) the cause of the removal was the different degree of 
inflammation, including PID. In the control group we have found no BV flora, and low level 
presence of bacteria/sample. As the period of wearing the IUD was getting longer a 
significant change was found in the culture results. We could detect increasing number of 
species/IUD, and more patients had BV flora. The species/IUD number elevated from 0.8 ( <5 
years) up to 5.8 ( >10 years). We saw the same significant change in the total CFUs from 
<103 (<5 years) to >107 (>10 years). 
4., The main interest of this thesis is the visualization of the bacterial biofilm on the surface of 
a removed IUD. After a precise preparation of the IUD stripes, the scanning electron 
microscoping was succesful, so we could make digitally recorded pictures of the biofilm. The 
immature and mature biofilm part also can be observed. The IUD's material differentiate 
craggy from the border of the biofilm. Such instrumental presentation with gynaecological 
inplant is extreme rare in international literature and it is the first time published in Hungary. 
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